Literature DB >> 30503777

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.

Ping Wu1, Christopher J Sneeringer2, Keith E Pitts2, Eric S Day3, Bryan K Chan4, Binqing Wei4, Isabelle Lehoux5, Kyle Mortara5, Hong Li6, Jiansheng Wu6, Yvonne Franke5, John G Moffat2, Jane L Grogan7, Timothy P Heffron4, Weiru Wang8.   

Abstract

Enhancement of antigen-specific T cell immunity has shown significant therapeutic benefit in infectious diseases and cancer. Hematopoietic progenitor kinase-1 (HPK1) is a negative-feedback regulator of T cell receptor signaling, which dampens T cell proliferation and effector function. A recent report showed that a catalytic dead mutant of HPK1 phenocopies augmented T cell responses observed in HPK1-knockout mice, indicating that kinase activity is critical for function. We evaluated active and inactive mutants and determined crystal structures of HPK1 kinase domain (HPK1-KD) in apo and ligand bound forms. In all structures HPK1-KD displays a rare domain-swapped dimer, in which the activation segment comprises a well-conserved dimer interface. Biophysical measurements show formation of dimer in solution. The activation segment adopts an α-helical structure which exhibits distinct orientations in active and inactive states. This face-to-face configuration suggests that the domain-swapped dimer may possess alternative selectivity for certain substrates of HPK1 under relevant cellular context.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HPK1; X-ray crystallography; cancer; immunology; inhibitor; kinase

Mesh:

Substances:

Year:  2018        PMID: 30503777     DOI: 10.1016/j.str.2018.10.025

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  9 in total

1.  Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation.

Authors:  Eric Johnson; Michele McTigue; Rebecca A Gallego; Ted W Johnson; Sergei Timofeevski; Michael Maestre; Timothy S Fisher; Robert Kania; Sansana Sawasdikosol; Steven Burakoff; Ciarán N Cronin
Journal:  J Biol Chem       Date:  2019-04-24       Impact factor: 5.157

2.  Identification of Potent Reverse Indazole Inhibitors for HPK1.

Authors:  Elsie C Yu; Joey L Methot; Xavier Fradera; Charles A Lesburg; Brian M Lacey; Phieng Siliphaivanh; Ping Liu; Dustin M Smith; Zangwei Xu; Jennifer A Piesvaux; Shuhei Kawamura; Haiyan Xu; J Richard Miller; Mark Bittinger; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2021-03-01       Impact factor: 4.345

3.  Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.

Authors:  Brandon A Vara; Samuel M Levi; Abdelghani Achab; David A Candito; Xavier Fradera; Charles A Lesburg; Shuhei Kawamura; Brian M Lacey; Jongwon Lim; Joey L Methot; Zangwei Xu; Haiyan Xu; Dustin M Smith; Jennifer A Piesvaux; J Richard Miller; Mark Bittinger; Sheila H Ranganath; David J Bennett; Erin F DiMauro; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2021-03-19       Impact factor: 4.345

4.  Using yeast surface display to engineer a soluble and crystallizable construct of hematopoietic progenitor kinase 1 (HPK1).

Authors:  Wai L Lau; Bradley Pearce; Heather Malakian; Iyoncy Rodrigo; Dianlin Xie; Mian Gao; Frank Marsilio; Chiehying Chang; Max Ruzanov; Jodi K Muckelbauer; John A Newitt; Daša Lipovšek; Steven Sheriff
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-12-22       Impact factor: 1.056

5.  Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).

Authors:  Bryan K Chan; Eileen Seward; Michael Lainchbury; Thomas F Brewer; Le An; Toby Blench; Matthew W Cartwright; Grace Ka Yan Chan; Edna F Choo; Jason Drummond; Richard L Elliott; Emanuela Gancia; Lewis Gazzard; Baihua Hu; Graham E Jones; Xifeng Luo; Andrew Madin; Sushant Malhotra; John G Moffat; Jodie Pang; Laurent Salphati; Christopher J Sneeringer; Craig E Stivala; Binqing Wei; Weiru Wang; Ping Wu; Timothy P Heffron
Journal:  ACS Med Chem Lett       Date:  2021-12-08       Impact factor: 4.345

6.  Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1.

Authors:  Andrew P Degnan; Godwin K Kumi; Christopher W Allard; Erika V Araujo; Walter L Johnson; Kurt Zimmermann; Bradley C Pearce; Steven Sheriff; Alan Futran; Xin Li; Gregory A Locke; Dan You; John Morrison; Karen E Parrish; Caitlyn Stromko; Anwar Murtaza; Jinqi Liu; Benjamin M Johnson; Gregory D Vite; Mark D Wittman
Journal:  ACS Med Chem Lett       Date:  2021-02-19       Impact factor: 4.345

7.  An allosteric regulation mechanism of Arabidopsis Serine/Threonine kinase 1 (SIK1) through phosphorylation.

Authors:  Junxi Mu; Jiali Zhou; Qingqiu Gong; Qin Xu
Journal:  Comput Struct Biotechnol J       Date:  2021-12-28       Impact factor: 7.271

8.  Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening.

Authors:  Huizhen Ge; Lizeng Peng; Zhou Sun; Huanxiang Liu; Yulin Shen; Xiaojun Yao
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

Review 9.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.